MetaCap

Axogen Earnings

NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

36.13-0.05 (-0.14%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.03

Axogen earnings summary

Axogen is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.03. In its most recent report on Jul 29, 2026 (Q2 2026), AXGN posted EPS of $-0.03. Revenue for the quarter was $69.7 million.

Quarterly EPS is down 400.0% from the same quarter a year earlier. Across the last 16 reports, AXGN shares moved an average of 7.1% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

AXGN earnings history

Axogen reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 29, 2026—$-0.03—+10.0%
Apr 28, 2026—$-0.38—-2.8%
Feb 24, 2026—$-0.28—-10.0%
Oct 29, 2025—$0.01—+6.1%
Aug 5, 2025—$0.01—+7.4%
May 8, 2025—$-0.08—+4.0%
Feb 26, 2025—$0.00—-11.4%
Nov 7, 2024—$-0.04—-0.2%
Aug 8, 2024—$-0.04—+6.4%
May 2, 2024—$-0.15—-0.7%
Mar 5, 2024—$-0.08—-12.2%
Nov 7, 2023—$-0.10—+17.1%
Aug 8, 2023—$-0.16—-5.3%
May 9, 2023—$-0.17—+0.5%
Mar 14, 2023—$-0.14—+10.2%
Nov 8, 2022—$-0.10—-9.6%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related